New Nature Communications Publication by FAKnostics!
FAKnostics, LLC is proud to announce a new open-access publication in Nature Communications lead by our CSO, Timothy Marlowe, Ph.D.!
In collaboration with the University of Arizona College of Medicine - Phoenix, Arizona State University, and the Blas Cabrera Institute of Physical Chemistry in Madrid, FAKnostics, LLC is the first to illustrate the scientific basis and preclinical efficacy of targeting the FAK scaffold and its superiority to targeting the FAK kinase.
The published work focuses on the discovery of hydrocarbon-stapled paxillin peptides, that block Focal Adhesion Kinase (FAK) scaffolding, and its potential use in cancer as well as other fibrotic diseases. hashtag#FAK hashtag#Cancer hashtag#DrugDiscovery hashtag#Fibrosis
Publication Link:Â https://lnkd.in/gU_4hv7s
To learn more about FAKnostics, LLC and how we have reimagined FAK therapeutics, please visit our website: www.faknostics.com
